Get startedLog in
    Picture of Lipella Pharmaceuticals logo

    LIPO — Lipella Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapValue Trap
    All News

    Brief: Following Guidance from U.S. Food & Drug Administration in Type-C Meeting Lipella Pharmaceuticals to Advance Lead Product Candidate to Phase 2b

    Picture of Lipella Pharmaceuticals logoLipella Pharmaceuticals
    21/05/2024 13:11
    May 21 (Reuters) - Lipella Pharmaceuticals Inc  LIPO.O :
    * FOLLOWING GUIDANCE FROM U.S. FOOD & DRUG ADMINISTRATION IN
TYPE-C MEETING LIPELLA PHARMACEUTICALS TO ADVANCE LEAD PRODUCT
CANDIDATE TO PHASE 2B
    * LIPELLA PHARMACEUTICALS-SEES TO INITIATE PHASE 2B CLINICAL
TRIAL
EVALUATING LP-10 AS TREATMENT FOR HEMORRHAGIC CYSTITIS IN H2
2024

Source text for Eikon:  ID:nGNX1Mrj9t 
Further company coverage:  LIPO.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Lipella Pharmaceuticals

    See all news